Literature DB >> 10375007

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.

D F Lewis1, B G Lake, M Dickins, P J Eddershaw, M H Tarbit, P S Goldfarb.   

Abstract

1. Molecular modelling studies of CYP2B isoforms from rat (CYP2B1), rabbit (CYP2B4) and man (CYP2B6) are reported, with particular emphasis on substrate interactions with the human CYP2B isoform, CYP2B6. 2. The findings represent an advance on our previous study that focused primarily on the rat CYP2B isoform, CYP2B1, and involved homology modelling with substrate-free CYP102. 3. The current work utilizes the recently published substrate-bound CYP102 crystal structure as a template for construction of the CYP2B subfamily isoforms and shows, in particular, that known CYP2B6 substrate specificity and regioselectivity can be rationalized by putative active site interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375007     DOI: 10.1080/004982599238560

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  5 in total

Review 1.  Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry.

Authors:  Pan-Fen Wang; Alicia Neiner; Evan D Kharasch
Journal:  Drug Metab Dispos       Date:  2019-07-19       Impact factor: 3.922

2.  Explicit water near the catalytic I helix Thr in the predicted solution structure of CYP2A4.

Authors:  Anna Gorokhov; Masahiko Negishi; Eric F Johnson; Lars C Pedersen; Lalith Perera; Tom A Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

3.  Quantitative structure-activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s.

Authors:  David F V Lewis
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

4.  Halogen Substitution Influences Ketamine Metabolism by Cytochrome P450 2B6: In Vitro and Computational Approaches.

Authors:  Pan-Fen Wang; Alicia Neiner; Thomas R Lane; Kimberley M Zorn; Sean Ekins; Evan D Kharasch
Journal:  Mol Pharm       Date:  2019-01-10       Impact factor: 5.364

5.  Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance.

Authors:  Ulrich M Zanger; Kathrin Klein
Journal:  Front Genet       Date:  2013-03-05       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.